News
Adaptimmune and GSK’s novel T-cell therapy works in solid tu...
Adaptimmune has more good news from its SPEAR T-cell therapy, yesterday unveiling encouraging early results in four patients with myxoid/round cell liposarcoma (MRCLS).
